CRISPR Therapeutics AG
CRSP
Market Cap$4.71B
Close$
$-3.76
107.1% downside
Current Fair Value
107.1% downsideOvervalued by 107.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.71 Billion |
|---|---|
| Enterprise Value | $4.74 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.34 |
| Beta | 1.8 |
| Outstanding Shares | 87,069,690 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.65 |
|---|---|
| PEG | -14.85 |
| Price to Sales | - |
| Price to Book Ratio | 2.79 |
| Enterprise Value to Revenue | 129.75 |
| Enterprise Value to EBIT | -8.85 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About CRISPR Therapeutics AG
CEO: Samarth Kulkarni